Shares of Evoke plc (LON:EVOK – Get Free Report) traded down 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares changed hands during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
Several equities research analysts have recently weighed in on EVOK shares. Berenberg Bank reduced their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.
Check Out Our Latest Stock Report on EVOK
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last released its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Equities research analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Activity
In other Evoke news, insider Andrea Gisle Joosen bought 14,572 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- Stock Market Sectors: What Are They and How Many Are There?
- MarketBeat Week in Review – 03/24 – 03/28
- Market Cap Calculator: How to Calculate Market Cap
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- 3 Best Fintech Stocks for a Portfolio Boost
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.